BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3936102)

  • 1. EEG effects of subcutaneous and intracerebroventricular injections of arginine vasopressin in the rat.
    Ehlers CL; Reed TK; Wang M; Lebrun CJ; Koob GF
    Psychopharmacology (Berl); 1985; 87(4):430-3. PubMed ID: 3936102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central injections of arginine vasopressin prolong extinction of active avoidance.
    Koob GF; Dantzer R; Bluthé RM; Lebrun C; Bloom FE; Le Moal M
    Peptides; 1986; 7(2):213-8. PubMed ID: 3737445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin antagonists block peripheral as well as central vasopressin receptors.
    De Wied D; Gaffori O; Van Ree JM; De Jong W
    Pharmacol Biochem Behav; 1984 Sep; 21(3):393-400. PubMed ID: 6093152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin analgesia: specificity of action and non-opioid effects.
    Kordower JH; Bodnar RJ
    Peptides; 1984; 5(4):747-56. PubMed ID: 6494025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of centrally injected AVP on heart rate, core temperature, and behavior in rats.
    Diamant M; De Wied D
    Am J Physiol; 1993 Jan; 264(1 Pt 2):R51-61. PubMed ID: 8430886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential cardiovascular effects of centrally administered vasopressin in conscious Long Evans and Brattleboro rats.
    Harland D; Gardiner SM; Bennett T
    Circ Res; 1989 Oct; 65(4):925-33. PubMed ID: 2791228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopressin alters female sexual behaviour by acting on the brain independently of alterations in blood pressure.
    Södersten P; Henning M; Melin P; Ludin S
    Nature; 1983 Feb 17-23; 301(5901):608-10. PubMed ID: 6828140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressin and the kindling of seizures.
    Corcoran ME; Cain DP; Finlay JM; Gillis BJ
    Life Sci; 1984 Aug; 35(9):947-52. PubMed ID: 6472059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of intracerebroventricular versus intravenous administration of vasopressin on intracranial pressure in the rat.
    Saladin LK; Bruni JE
    Neurol Res; 1993 Jun; 15(3):198-203. PubMed ID: 8103586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of subcutaneous administration of arginine-8-vasopressin on the electroencephalogram of conscious rats are mediated by peripheral vasopressin V1 receptors.
    Ebenezer IS
    Methods Find Exp Clin Pharmacol; 1994 Jun; 16(5):315-21. PubMed ID: 7934310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure to kindle seizures after repeated intracerebral administration of arginine vasopressin.
    Cain DP; Plant J; Rouleau S; Corcoran ME
    Life Sci; 1986 Mar; 38(11):985-9. PubMed ID: 3951322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor disturbances and neurotoxicity induced by centrally administered somatostatin and vasopressin in conscious rats: interactive effects of two neuropeptides.
    Balaban CD; Fredericks DA; Wurpel JN; Severs WB
    Brain Res; 1988 Mar; 445(1):117-29. PubMed ID: 2896527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barrel rotation evoked by intracerebroventricular vasopressin injections in conscious rats. I. Description and general pharmacology.
    Wurpel JN; Dundore RL; Barbella YR; Balaban CD; Keil LC; Severs WB
    Brain Res; 1986 Feb; 365(1):21-9. PubMed ID: 3947985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central vasopressin in the modulation of catecholamine release in conscious rats.
    King KA; Mackie G; Pang CC; Wall RA
    Can J Physiol Pharmacol; 1985 Dec; 63(12):1501-5. PubMed ID: 3830349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic cardiovascular effects of central vasopressin in conscious rats.
    Tsuchihashi T; Takata Y; Tomita Y; Takishita S; Nakao Y; Kobayashi K; Fujishima M
    Clin Exp Hypertens A; 1992; 14(4):699-716. PubMed ID: 1352744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular responses to intrathecal administration of arginine vasopressin in rats.
    Riphagen CL; Pittman QJ
    Regul Pept; 1985 Apr; 10(4):293-8. PubMed ID: 3839086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopressin: mechanism of central cardiovascular action in conscious rats.
    Rohmeiss P; Becker H; Dietrich R; Luft F; Unger T
    J Cardiovasc Pharmacol; 1986; 8(4):689-96. PubMed ID: 2427805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central ANP attenuates pressor responses to central AVP in WKY and SHR.
    Stepniakowski K; Budzikowski A; Lon S; Szczepanska-Sadowska E
    Brain Res Bull; 1991 Aug; 27(2):247-9. PubMed ID: 1835898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brattleboro rats display increased sensitivity to arginine vasopressin-induced motor disturbances.
    Burnard DM; Pittman QJ; Veale WL
    Brain Res; 1985 Sep; 342(2):316-22. PubMed ID: 4041833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arginine vasopressin does not contribute to seizures induced by intracerebroventricularly-injected pilocarpine.
    Gulec G; Isbil-Buyukcoskun N
    Neuropeptides; 2005 Dec; 39(6):575-9. PubMed ID: 16246417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.